SCHEMBL982617

SCHEMBL982617

O=C(Cc1cccs1)N1CCC(c2ccc(Cl)cc2)=N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
LMNA P02545 4/20 0.53
MAPT P10636 2/20 0.53
HTT P42858 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PGR P06401 4/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HPGD P15428 2/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PKM P14618 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981784 0.88 ALDH1A1 (0.49) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL982365 0.87 KDM4E (0.55) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL981499 0.85 ALDH1A1 (0.45) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL982411 0.84 MAPT (0.55) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL982034 0.83 ALDH1A1 (0.50) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL980554 0.82 HPGD (0.48) ALDH1A1LMNAMAPTHSD17B10MAPK1
SCHEMBL979242 0.80 ALDH1A1 (0.56) ALDH1A1LMNAMAPTSMN1; SMN2PGR
SCHEMBL982164 0.79 KDM4E (0.48) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL980170 0.77 KMT2A (0.56) ALDH1A1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL982007 0.77 ME2 (0.51) ALDH1A1LMNAMAPTSMN1; SMN2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP disclosed